Extended-release niacin formulations may cause less glucose elevation than immediate-release products but carry a higher risk of hepatotoxicity
An important role is to inactivate incretins (GLP-1 & GIP)
pharmacies Board-certified Before Lost 132 lbs verified After Compounded GLP-1 Doctor-prescribed shipped to your door New Medicare GLP-1 Bridge FDA-approved GLP1s for a $50 copay
Commercial insurance approval rates: Mounjaro (diabetes): 75-85% approval rate
rebranded to Ozempic pill): 2% of patients taking the 14 mg dose
Find out more: How we vet brands and products July 10, 2026: Most Weight-Loss Drugs Do Not Improve Quality of Life or Heart Health July 6, 2026: Generic Mounjaro, Zepbound May Be Coming, Rivaling Current GLP-1s June 29, 2026: GLP-1s Like Ozempic, Mounjaro Linked to Reduced Stroke, Heart Risk June 26, 2026: Can GLP-1 Weight Loss Drugs Give Athletes an Unfair Advantage